# Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

> **NCT01977352** · PHASE4 · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 42 (actual)

## Conditions studied

- Shoulder Pain
- Rotator Cuff Tear

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine 0.25%

## Key facts

- **NCT ID:** NCT01977352
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977352, "Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01977352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
